---

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

April 7, 2003

Date of Report

(Date of earliest event reported)

 

---

 

RITA Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 

---

 

Delaware

(State or other jurisdiction of incorporation)

 

000-30959		94-3199149
(Commission File Number)		(I.R.S. Employer Identification No.)

 

967 N. Shoreline Blvd.

Mountain View, CA 94043

(Address of principal executive offices, with zip code)

 

(650) 314-3400

(Registrant’s telephone number, including area code)

 

---

---

 

Item 5. Other Events and Required FD Disclosure.

 

On April 7, 2003 RITA Medical Systems, Inc. (the “Company”) announced the settlement of its patent disputes with Boston Scientific Corporation. A copy of the press release dated April 7, 2003 announcing the settlement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

 

(a)

Financial Statements: Not Applicable.

 

(b)

Pro Forma Financial Information: Not Applicable.

 

(c)

Exhibits:

 

99.1 Press Release of RITA Medical Systems, Inc. dated April 7, 2003.

 

-2-

---

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

						RITA Medical Systems, Inc.
Date: April 7, 2003						By:		/s/    DONALD STEWART
								Donald Stewart Chief Financial Officer and Vice President, Finance and Administration (Principal Financial and Accounting Officer)

---

 

RITA MEDICAL SYSTEMS, INC.

 

INDEX TO EXHIBITS

 

Exhibit Number		Description
99.1		Press Release of RITA Medical Systems, Inc. dated April 7, 2003.